Skip to main content

Laurie H Sanders

Associate Professor in Neurology
Neurology, Translational Brain Sciences
Box 103056, 3 Genome Court 5128 MSRB III, Durham, NC 27713
Box 103056, 3 Genome Court 5128 MSRB III, Durham, NC 27713

Current Appointments & Affiliations


Associate Professor in Neurology · 2025 - Present Neurology, Translational Brain Sciences, Neurology
Associate Professor of Pathology · 2022 - Present Pathology, Clinical Science Departments
Member of the Duke Cancer Institute · 2019 - Present Duke Cancer Institute, Institutes and Centers
Member in the Duke Clinical Research Institute · 2021 - Present Duke Clinical Research Institute, Institutes and Centers

In the News


Published March 27, 2025
A Test for Parkinson’s Could Offer Hope to Millions. A Funding Freeze May Stall It.
Published August 31, 2023
New Blood Test Detects Parkinson’s Disease

View All News

Recent Publications


G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage.

Journal Article NPJ Parkinsons Dis · March 1, 2024 Pathogenic mutations in LRRK2 cause Parkinson's disease (PD). The G2019S variant is the most common, which results in abnormally high kinase activity. Compounds that target LRRK2 kinase activity are currently being developed and tested in clinical trials. ... Full text Link to item Cite

Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson's disease.

Journal Article Sci Rep · October 18, 2023 Parkinson's disease (PD) is one of the most common neurodegenerative diseases, but no disease modifying therapies have been successful in clinical translation presenting a major unmet medical need. A promising target is alpha-synuclein or its aggregated fo ... Full text Link to item Cite

A blood-based marker of mitochondrial DNA damage in Parkinson's disease.

Journal Article Sci Transl Med · August 30, 2023 Parkinson's disease (PD) is the most common neurodegenerative movement disorder, and neuroprotective or disease-modifying interventions remain elusive. High-throughput markers aimed at stratifying patients on the basis of shared etiology are required to en ... Full text Link to item Cite
View All Publications

Recent Grants


The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2029

Duke University Program in Environmental Health

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029

Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)

ResearchCo-Principal Investigator · Awarded by National Institute on Aging · 2023 - 2028

View All Grants

Education, Training & Certifications


University at Buffalo, Jacobs School of Medicine and Biomedical Sciences · 2008 Ph.D.